HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Basal Ganglia Hemorrhage

Bleeding within the subcortical regions of cerebral hemispheres (BASAL GANGLIA). It is often associated with HYPERTENSION or ARTERIOVENOUS MALFORMATIONS. Clinical manifestations may include HEADACHE; DYSKINESIAS; and HEMIPARESIS.
Also Known As:
Basal Ganglionic Hemorrhage; Hematoma, Basal Ganglia; Ganglionic Hemorrhage, Basal; Hemorrhage, Basal Ganglionic; Hemorrhage, Basal Ganglia
Networked: 69 relevant articles (8 outcomes, 11 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hematoma
2. Intracranial Hemorrhages (Intracranial Hemorrhage)
3. Acute Subdural Hematoma
4. Infections
5. Hemorrhage

Experts

1. Dai, Wei-Min: 2 articles (06/2022 - 01/2013)
2. Guo, Hao: 2 articles (08/2021 - 01/2020)
3. Guo, Wei: 2 articles (08/2021 - 01/2020)
4. Qu, Yan: 2 articles (08/2021 - 01/2020)
5. Wu, Xun: 2 articles (08/2021 - 01/2020)
6. Wu, Dan: 2 articles (04/2017 - 01/2015)
7. Dong, Xiao-Qiao: 2 articles (08/2010 - 06/2010)
8. Hu, Yue-Yu: 2 articles (08/2010 - 06/2010)
9. Yu, Wen-Hua: 2 articles (08/2010 - 06/2010)
10. Zhang, Zu-Yong: 2 articles (08/2010 - 06/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Basal Ganglia Hemorrhage:
1. Macrophage Colony-Stimulating FactorIBA
2. XenonIBA
3. Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
4. C-Reactive ProteinIBA
5. CytokinesIBA
6. Tissue Plasminogen Activator (Alteplase)FDA Link
7. Blood Glucose (Blood Sugar)IBA
8. Nicotinamide PhosphoribosyltransferaseIBA
9. ResistinIBA
10. Therapeutic UsesIBA

Therapies and Procedures

1. Punctures
2. Conservative Treatment
3. Catheters
4. Craniotomy
5. Therapeutics